Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.08.23 | SIGA Technologies - Second quarter as expected, onward to H223 | 544 | Edison Investment Research | SIGA has reported Q223 results, which came in largely as expected, and management has provided key operational highlights. Activity in the second half of the year has started to firm up with upcoming... ► Artikel lesen | |
10.08.23 | Checkit - Trading on track in tough environment | 306 | Edison Investment Research | Checkit made good progress in H124, growing annual recurring revenue (ARR) by 24% y-o-y and revenue by 19% y-o-y. Net revenue retention of 113% highlights the company's ability to cross-sell and upsell... ► Artikel lesen | |
10.08.23 | Actinogen Medical - Funding the next stage of Xanamem development | 401 | Edison Investment Research | Actinogen recently provided a Q423 quarterly update summarising that its two development programmes for lead candidate Xanamem remain on track, with the Phase IIb XanaMIA study portion assessing the... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 353 |
EVOTEC | 319 |
TUI | 232 |
NVIDIA | 194 |
DEUTSCHE BANK | 189 |
BAYER | 172 |
PLUG POWER | 156 |
RHEINMETALL | 147 |
NEL | 143 |
SIEMENS ENERGY | 129 |
COMMERZBANK | 115 |
BARRICK GOLD | 114 |
TESLA | 112 |
BASF | 110 |
VOLKSWAGEN | 105 |
RWE | 100 |
DEUTSCHE LUFTHANSA | 97 |
BYD | 95 |
ALLIANZ | 91 |
DEUTSCHE TELEKOM | 90 |
MERCEDES-BENZ | 89 |
RENK GROUP | 85 |
E.ON | 83 |
HEIDELBERGER DRUCK | 80 |
REDCARE PHARMACY | 78 |